LY3200882
LY3200882 is a potent and selective TGFβRI kinase inhibitor. It is a valuable research tool for studying TGF-β signaling in cancer biology and fibrosis, with demonstrated utility in both cellular assays and in vivo animal models.
Product Specifications
CAS Number
1898283-02-7
Product Name Alternative
Inhibit, immune, LY3200882, LY-3200882, LY 3200882, Inhibitor, ALK5, ATP-competitive, Anti-cancer, anti-metastatic, serine-threonine, phosphorylation, TGFb, TGF-b/Smad, TGFbeta/Smad, TGF-beta, TGFbeta, TGF-β Receptor, TGF-β/Smad, TGFβ, SMAD, Smad, TGF-βRI (ALK5), TGFβRI, Transforming growth factor beta receptors
Field of Research
Stem Cell & Developmental Biology
Purity
98.37% (May vary between batches)
Solubility
DMSO:4.36 mg/mL (10.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.3 mM)
Smiles
CC (C) (O) c1cc (Nc2cc (Oc3cn (nc3C3CCOCC3) C3CC3) ccn2) ccn1
Molecular Formula
C24H29N5O3
Molecular Weight
435.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal UCMA Antibody [DyLight 488]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
